Dr. Andrea Barberis | Health Sciences | Excellence Award (Any Scientific field)

Dr. Andrea Barberis | Health Sciences | Excellence Award (Any Scientific field)

EO Galliera Hospitals, Genoa, Italy

Dr. Andrea Barberis  is a distinguished Italian surgeon with a specialization in general and hepatobiliopancreatic surgery. Currently serving as Dirigente Medico di Primo Livello at the Ente Ospedaliero Ospedali Galliera in Genova, Liguria since 2018, he plays a pivotal role in clinical care and surgical innovation. Dr. Barberis is well recognized within Italian surgical societies for his contributions to both clinical practice and research, particularly in colorectal, emergency, and gastrointestinal surgery.

Publication Profile

🎓 Education Background:

Dr. Barberis earned his specialization in General Surgery from the Università degli Studi di Genova, one of Italy’s premier institutions for medical education. His advanced training has equipped him with the skills to tackle complex surgical conditions, especially in hepatobiliopancreatic and digestive tract domains.

💼 Professional Experience:

Since January 2018, Dr. Barberis has been affiliated with the Ente Ospedaliero Ospedali Galliera in Genoa, where he serves in a leading capacity within the General and Hepatobiliopancreatic Surgery Department. His professional journey reflects not only a commitment to surgical excellence but also active involvement in national surgical networks. He is a member of the Società Ligure di Chirurgia since 2018 and part of the Comitato Nazionale ACOI Giovani (Italian Hospital Surgeons Association) from 2021 to 2024.

🏅 Awards and Honors:

While individual awards are not specifically listed, Dr. Barberis’s leadership roles and active presence in Italy’s most prestigious surgical societies such as ACOI and Società Ligure di Chirurgia are testament to his professional standing and peer recognition.

🔬 Research Focus:

Dr. Barberis’s research interests are deeply rooted in colorectal cancer, minimally invasive surgical techniques, emergency surgery, venous thromboembolism prophylaxis, and digestive tract management, as evidenced by his prolific publication record. He employs machine learning, cross-sectional surveys, and clinical cohort studies to derive impactful insights that advance surgical practice.

🧾 Conclusion:

Dr. Andrea Barberis continues to make significant strides in the field of surgery through his clinical roles, national committee engagements, and high-impact research. A committed physician-scientist, his contributions reflect a blend of surgical precision and academic rigor, helping shape the future of Italian and global surgical practice.

📚 Top Publications with Details:

Dynamic Prediction of Rectal Cancer Relapse and Mortality Using a Landmarking-Based Machine Learning Model
Journal: Cancers | Year: 2025
Cited by: [Available on publisher site]

Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey
Journal: Updates in Surgery | Year: 2025
Cited by: [Available on publisher site]

Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey
Journal: Updates in Surgery | Year: 2025
Cited by: [Available on publisher site]

Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery
Journal: The British Journal of Surgery | Year: 2025
Cited by: PMC11894929

Acute diverticulitis management: evolving trends among Italian surgeons
Journal: Updates in Surgery | Year: 2024
Cited by: PMC11455713

Juan Valdivieso | Health Sciences | Best Researcher Award

Mr. Juan Valdivieso | Health Sciences | Best Researcher Award

Research Lead, Savana, Spain

Dr. Juan Valdivieso is a distinguished medical professional specializing in immunology and oncology. He completed his medical degree in Ecuador and furthered his education in Spain, where he gained expertise in immuno-oncology. With extensive experience in both clinical practice and research, Dr. Valdivieso is currently a Medical Research Lead at SavanaResearch, Madrid. His work, particularly in the areas of rheumatoid arthritis and CAR-T cell monitoring, has been published in renowned scientific journals.

Publication Profile

Scopus

Strengths for the Award:

  1. Extensive Research Background: Dr. Juan Luis Valdivieso Shephard has a strong research background, with several publications in prestigious journals like Rheumatology (Oxford) and Heliyon. His work covers critical areas such as immunology, oncology, and artificial intelligence in medical research.
  2. Diverse Clinical Experience: He has gained significant clinical experience through his residency in immunology, rotations in oncology, and work as a medical researcher. This practical experience complements his research, making his contributions valuable in both clinical and research settings.
  3. Active in Scientific Community: Dr. Valdivieso Shephard has actively participated in various national and international conferences, presenting his research findings. His involvement in these events highlights his commitment to advancing his field and sharing knowledge with the broader scientific community.
  4. Collaborative Researcher: He has collaborated with various experts, contributing to multi-author publications and book chapters. This ability to work in a team and contribute to significant scientific literature is a strong point in his favor.
  5. Language Proficiency: Proficiency in both Spanish and English enables him to engage with a broader audience, increasing the impact of his research internationally.

Areas for Improvement:

  1. Further Specialization: While Dr. Valdivieso Shephard has a broad research portfolio, focusing more deeply on a specific niche within immunology or oncology could enhance his expertise and make him a leading figure in that area.
  2. Leadership Roles: Taking on more leadership roles in research projects or professional organizations could strengthen his profile. Mentoring junior researchers and leading large-scale studies would further demonstrate his capabilities.
  3. Grant Acquisition: Securing more research grants and funding would not only boost his research endeavors but also underscore his ability to attract resources, a key criterion for many research awards.

Education 🎓

Dr. Valdivieso earned his medical degree from the University of Cuenca, Ecuador, in 2013. He later obtained the Spanish equivalency of his medical degree in 2016. He completed a residency in immunology at Hospital Universitario La Paz in Madrid, Spain, from 2017 to 2021, followed by a master’s degree in Immuno-Oncology from Universidad Rey Juan Carlos, which he completed in 2023.

Experience 🏥

Dr. Valdivieso’s career began in Ecuador, where he served as a rural physician and later as an Onco-hematology doctor at Hospital José Carrasco Arteaga. Since 2021, he has been the Medical Research Lead at SavanaResearch in Madrid, Spain. His professional background also includes occasional teaching roles at MIR MediPlus.

Research Focus 🔬

Dr. Valdivieso’s research primarily focuses on immunology, oncology, and the application of artificial intelligence in medical research. His notable projects include studying anti-TNF treatment responses in rheumatoid arthritis and standardizing CAR-T cell monitoring techniques.

Awards and Honors 🏅

Throughout his career, Dr. Valdivieso has received recognition for his contributions to medical research, particularly in the field of immunology. His work has been cited in numerous scientific publications, reflecting the impact of his research on the medical community.

Publication Top Notes 📚

“Colitis expands the phenotype of PAAND patients: new case report and review of the literature”Rheumatology (Oxford), 2021
Cited by 5 articles

“Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual development”Rheumatology, 2021
Cited by 7 articles

“Variants in CASP10, a diagnostic challenge: Single center experience and review of the literature”Clinical Immunology, 2021
Cited by 4 articles

“Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters”Heliyon, 2024
Cited by 3 articles

“The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR technique”Cytometry Part A, 2024
Cited by 2 articles

Conclusion:

Dr. Juan Luis Valdivieso Shephard is a strong candidate for the Best Researcher Award, given his extensive research experience, active participation in the scientific community, and contributions to immunology and oncology. His strengths, particularly in research and collaboration, make him a worthy contender. However, focusing on further specialization and leadership in research could enhance his candidacy for future awards.